Prostaglandin-mediated hypercalcemia in the VX2 carcinoma-bearing rabbit

H. W. Seyberth, W. C. Hubbard, O. Oelz, B. J. Sweetman, J. T. Watson, J. A. Oates

Research output: Contribution to journalArticlepeer-review

36 Scopus citations


Prostaglandin biosynthesis and metabolism were studied in the VX2 carcinoma-bearing rabbit, an animal model of prostaglandin-mediated hypercalcemia. All the identification and quantification of the prostaglandins were done by gas chromatography-mass spectrometry. The tumor incubated in vitro converted exogeneous arachidonic acid principally to PGE2. Biosynthesis from endogenous precursor lipids yields mainly PGE2 and PGF2α. The 100,000 × g supernatant fluid of the tumor did not contain any metabolizing enzymes. Significant hypercalcemia developed between the first and second week after tumor implantation. The levels of the major plasma metabolite of PGE2, 15-keto-13,14-dihydro-PGE2, became elevated at one week, had risen 25-fold by the end of the second week, and at the fourth week were elevated to 256 times the pre-incubation levels. The concentration of 15-keto-13,14-dihydro-PGF2α in plasma rose in parallel but to a lesser degree. 7α-hydroxy-5,11-diketotetranor-prostane-1,16-dioic acid, the major urinary metabolite of the E prostaglandins, was elevated two weeks after tumor implantation and rose until the fifth week. Indomethacin treatment lowered both serum calcium and the plasma level of 15-keto-13,14-dihydro-PGE2.

Original languageEnglish (US)
Pages (from-to)319-331
Number of pages13
Issue number2
StatePublished - Aug 1977
Externally publishedYes

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology


Dive into the research topics of 'Prostaglandin-mediated hypercalcemia in the VX2 carcinoma-bearing rabbit'. Together they form a unique fingerprint.

Cite this